Image-guided percutaneous lung biopsy shows over 90% diagnostic yield for malignancy in patients, suggesting improved safety protocols.
Image-guided percutaneous lung biopsy is a commonly performed procedure that provides cells or tissue for pathologic diagnosis, typically under computed tomography (CT) guidance. The most common indication is evaluation of a suspicious pulmonary nodule concerning for malignancy, for which percutaneous lung biopsy has a diagnostic yield of > 90%.[1] [2] These lesions may be found incidentally, during low-dose lung cancer screening, or as part of the evaluation of a symptomatic patient. Beyond primary malignancy, percutaneous lung biopsy may be used for staging in patients with lung nodules in the setting of known extra-thoracic malignancy, or in cases of persistent pulmonary infection despite empiric treatment.
No takes yet. Share an insight, caveat, or question.
Zane et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: